Probiotics: As good as advertised?

“Take a few billion bacteria and call me in the morning.” With all the advertising attention paid to probiotics these days, it seems that this unlikely remedy might be the best prescription for many ailments. Are the results as good as advertised, and are these “good” bacteria really safe? Recent research sheds some light on the subject.

GIA physicians routinely exceed national quality goal for colonoscopy

The specialist physicians at Gastrointestinal Associates who perform patient colonoscopies have consistently surpassed an important national quality benchmark for that procedure. The American Society of Gastrointestinal Endoscopy set a benchmark of 95 for the percentage of colonoscopies in which the entirety of the colon was examined.

May is National Celiac Awareness Month

Gastrointestinal Associates’ Dr. Sarkis Chobanian appeared on WBIR-Channel 10 to discuss the increasing prevalence of the disease caused by gluten intolerance. His recent blog article on the subject helps explain why more people are dealing with a celiac disease diagnosis.  

May is National Celiac Disease Awareness Month

If it seems like you’re hearing more about gluten-free diets and celiac disease, you are. The condition is increasingly common. According to a several recent studies reported in The American Journal of Gastroenterology, celiac disease is an increasingly common disease that affects 3.1 million Americans. Celiac disease is an immune-based reaction to dietary gluten (a protein contained in wheat, barley, … Read More

Are Antibiotics Making Patients Sick?

When you get sick, do you immediately think a prescription for antibiotics would help? Worse yet, do you take what’s left of an old antibiotic prescription? There is no doubt that antibiotics can be a vitally important medical tool that are effective in treating bacterial infections, certain fungal infections and some kinds of parasites. They are not, however, useful in … Read More

Statins May Reduce Esophageal Cancer Risk

A recent study indicates that statins, the cholesterol-reducing drugs taken by millions of Americans, may have the added benefit of reducing the risk of developing esophageal cancer (cancer of the esophagus).